David P. Hochman - 04 Aug 2025 Form 4 Insider Report for Orchestra BioMed Holdings, Inc. (OBIO)

Role
Chief Executive Officer and Chairperson, Director
Signature
/s/ Andrew Taylor, Attorney-in-Fact
Issuer symbol
OBIO
Transactions as of
04 Aug 2025
Net transactions value
+$55,000
Form type
4
Filing time
04 Aug 2025, 18:16:12 UTC
Previous filing
13 Jun 2025
Next filing
08 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hochman David P Chief Executive Officer and Chairperson, Director C/O ORCHESTRA BIOMED HOLDINGS, INC., 150 UNION SQUARE DRIVE, NEW HOPE /s/ Andrew Taylor, Attorney-in-Fact 04 Aug 2025 0001292834

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OBIO Common Stock, par value $0.0001 per share ("Common Stock") Purchase $55,000 +20,000 +6.1% $2.75 349,331 04 Aug 2025 By the DPH 2008 Trust F1
holding OBIO Common Stock 545,460 04 Aug 2025 Direct
holding OBIO Common Stock 2,000 04 Aug 2025 By the Solomon Ascher Hochman 2019 Trust
holding OBIO Common Stock 2,000 04 Aug 2025 By the Hannah Hochman 2019 Trust
holding OBIO Common Stock 2,000 04 Aug 2025 By the Judah Herman Hochman 2019 Trust
holding OBIO Common Stock 3,140 04 Aug 2025 By the NSH 2008 Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were purchased in an underwritten public offering of the Issuer at the public offering price of $2.75 per share.

Remarks:

Chief Executive Officer and Chairperson